Gsk PLC (GSK) SEC Filings — 2026
32 SEC filings for Gsk PLC (GSK) in 2026.
Filings
- GSK plc Files Director/PDMR Shareholding Report — 6-K · Apr 20, 2026
- GSK's BLENREP Approved in China for Multiple Myeloma — 6-K · Apr 20, 2026
- GSK plc Files Share Transaction Report (6-K) — 6-K · Apr 20, 2026
- GSK plc Files 6-K on Share Transaction — 6-K · Apr 17, 2026
- Gsk PLC 6-K Filing — 6-K · Apr 16, 2026
- Gsk PLC 6-K Filing — 6-K · Apr 16, 2026
- GSK plc Completes Acquisition of 35Pharma Inc. — 6-K · Apr 15, 2026
- Gsk PLC 6-K Filing — 6-K · Apr 15, 2026
- Gsk PLC 6-K Filing — 6-K · Apr 14, 2026
- Gsk PLC 6-K Filing — 6-K · Apr 13, 2026
- GSK plc Files Form 6-K on Share Transactions — 6-K · Apr 13, 2026
- GSK plc Files Director Shareholding Report — 6-K · Apr 10, 2026
- GSK plc Reports Share Transaction in 6-K Filing — 6-K · Apr 10, 2026
- GSK plc Files Director/PDMR Shareholding Report — 6-K · Apr 9, 2026
- Gsk PLC 6-K Filing — 6-K · Apr 9, 2026
- GSK plc Announces EXDENSUR Approval in China — 6-K · Apr 8, 2026
- Gsk PLC 6-K Filing — 6-K · Apr 8, 2026
- GSK plc Files 6-K on Share Transaction — 6-K · Apr 7, 2026
- Gsk PLC 6-K Filing — 6-K · Apr 2, 2026
- Gsk PLC 6-K Filing — 6-K · Apr 1, 2026
- GSK plc Files Share Transaction Report (6-K) — 6-K · Apr 1, 2026
- Gsk PLC 6-K Filing — 6-K · Apr 1, 2026
- Gsk PLC 6-K Filing — 6-K · Mar 31, 2026
- GSK's Bepirovirsen Accepted for Review in China — 6-K · Mar 30, 2026
- GSK's TRELEGY ELLIPTA approved for severe asthma in China — 6-K · Mar 30, 2026
- GSK plc Files 6-K on Share Transaction — 6-K · Mar 30, 2026
- Gsk PLC 6-K Filing — 6-K · Mar 27, 2026
- GSK's Bepirovirsen Accepted for EMA Review — 6-K · Mar 27, 2026
- GSK Files 6-K on Own Share Transactions — 6-K · Mar 26, 2026
- GSK plc Files 6-K for Annual General Meeting Notice — 6-K · Mar 25, 2026
- GSK plc Reports Transaction in Own Shares on March 25, 2026 — 6-K · Mar 25, 2026
- GSK Reports Own Share Transaction on March 24, 2026 — 6-K · Mar 24, 2026